Delisting of Securities of Rosetta Genomics Ltd., ConvergeOne Holdings, Inc. (Warrant Only), FC Global Realty Incorporated, Concordia International Corp., and Argos Therapeutics, Inc. from The Nasdaq Stock Market
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of Rosetta Genomics Ltd. Rosetta Genomics Ltd.’s stock was suspended on May 22, 2018 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the warrant of ConvergeOne Holdings, Inc. ConvergeOne Holdings, Inc.’s warrant was suspended on June 28, 2018 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of FC Global Realty Incorporated. FC Global Realty Incorporated’s stock was suspended on June 20, 2018 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of Concordia International Corp. Concordia International Corp.’s stock was suspended on June 08, 2018 and has not traded on Nasdaq since that time.
Finally, Nasdaq announced that it will delist the common stock of Argos Therapeutics, Inc. Argos Therapeutics, Inc.’s stock was suspended on April 25, 2018 and has not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.
NDAQO
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
